In PD, Lipopolysaccharide (LPS) can regulate cytokine release and modulate the immunological response by activating the Toll-like receptor (TLR)-linked signaling pathway and elevating the phosphorylation levels of MAPK and NF-kB pathways [36,37]. Here, NFKB1 is linked to Parkinson disease.